Role od promyelocytic leukemia (PML) protein in tumor suppression (2005)
- Authors:
- Autor USP: REGO, EDUARDO MAGALHAES - FMRP
- Unidade: FMRP
- Subjects: LEUCEMIA (GENÉTICA); GENÉTICA; APOPTOSE
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Journal of Experimental Medicine
- ISSN: 0022-1007
- Volume/Número/Paginação/Ano: v. 193, n. 4, p. 521-529, 2005
-
ABNT
REGO, Eduardo Magalhães et al. Role od promyelocytic leukemia (PML) protein in tumor suppression. Journal of Experimental Medicine, v. 193, n. 4, p. 521-529, 2005Tradução . . Acesso em: 25 abr. 2024. -
APA
Rego, E. M., Wang, Z. -G., Peruzzi, D., He, L. -Z., & Pandolfi, P. P. (2005). Role od promyelocytic leukemia (PML) protein in tumor suppression. Journal of Experimental Medicine, 193( 4), 521-529. -
NLM
Rego EM, Wang Z-G, Peruzzi D, He L-Z, Pandolfi PP. Role od promyelocytic leukemia (PML) protein in tumor suppression. Journal of Experimental Medicine. 2005 ; 193( 4): 521-529.[citado 2024 abr. 25 ] -
Vancouver
Rego EM, Wang Z-G, Peruzzi D, He L-Z, Pandolfi PP. Role od promyelocytic leukemia (PML) protein in tumor suppression. Journal of Experimental Medicine. 2005 ; 193( 4): 521-529.[citado 2024 abr. 25 ] - Trangenic mice expressing hCG-NuMA-RAR'alfa' develop hematopoietic abnormalities leading to acute promyelocytic leukemia
- Estudo da relevância da inativação do CCAAT enhancer binding protein 'alfa' (C/EBP'alfa') na gênese da leucemia promielocítica
- Linfomas não Hodgkin de células T maduras e de células NK extramodais
- Identification of myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia
- Thalidomide plus dexamethasone as a maintenance therapy after autologous hematopoietic stem cell transplantation improves progression-free survival in multiple myeloma
- Association between the TP53 Arg72Pro polymorphism and clinical outcomes in acute myeloid leukemia
- Florence: a randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS risk
- Anemia e palidez
- Temporal trends in Hematopoietic Stem Cell Transplantation in Argentina. [Editorial]: regional differences that mirror the global reality
- Tratamento das infecções em pacientes com pancitopenia secundária a tratamento citorredutor
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
